ロード中...
Case series: indoor-photosensitivity caused by fluorescent lamps in patients treated with vemurafenib for metastatic melanoma
BACKGROUND: Vemurafenib, a selective inhibitor of genetically activated BRAF, is registered for unresectable stage III and stage IV melanomas harboring a BRAF mutation. Photosensitivity related to exposure to sunlight is a common side-effect. We here present three cases of indoor-photosensitivity du...
保存先:
| 出版年: | BMC Cancer |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4301932/ https://ncbi.nlm.nih.gov/pubmed/25515496 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-967 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|